Immunohistochemical
Western blot
2.5 ug/ml| Product Name | C21orf33 antibody - N-terminal region |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | The immunogen for anti-C21orf33 antibody: synthetic peptide directed towards the N terminal of human C21orf33 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB,IHC |
| Species Reactivity | Human,Sheep |
| Concentration | 1mg/ml |
| Purification | Protein A |
| Gene Symbol | C21orf33 |
|---|---|
| Gene Synonyms | D21S2048E ES1 GT335 HES1 KNP-I KNPH KNPI |
| Gene Full Name | Chromosome 21 open reading frame 33 |
| Gene Summary | C21orf33 inhibits both estrogen- and heregulin-beta1-stimulated growth of breast cancer cells, and further suggests that growth inhibition induced in these cells by all-trans retinoic acid occurs via HES-1-mediated downregulation of E2F-1 expression. C21orf33 may also be a candidate protein involved in the pathogenesis of the brain deficit in DS. |
| Alternative Names | D21S2048E ES1 GT335 HES1 KNP-I KNPH KNPI |
| Molecular Weight(MW) | 21kDa |
| Sequence | 237 amino acids |
Immunohistochemical
Western blot
2.5 ug/ml| Form | Liquid |
|---|---|
| Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
